17-57979243-TTGCTGCTGCTGCTGC-T
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP3BP6_ModerateBS2
The ENST00000581208.2(VEZF1):c.1032_1046delGCAGCAGCAGCAGCA(p.Gln345_Gln349del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.00308 in 1,597,004 control chromosomes in the GnomAD database, including 8 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0022 ( 0 hom., cov: 28)
Exomes 𝑓: 0.0032 ( 8 hom. )
Consequence
VEZF1
ENST00000581208.2 disruptive_inframe_deletion
ENST00000581208.2 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.35
Genes affected
VEZF1 (HGNC:12949): (vascular endothelial zinc finger 1) Transcriptional regulatory proteins containing tandemly repeated zinc finger domains are thought to be involved in both normal and abnormal cellular proliferation and differentiation. ZNF161 is a C2H2-type zinc finger protein (Koyano-Nakagawa et al., 1994 [PubMed 8035792]). See MIM 603971 for general information on zinc finger proteins.[supplied by OMIM, Sep 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP3
Nonframeshift variant in repetitive region in ENST00000581208.2
BP6
Variant 17-57979243-TTGCTGCTGCTGCTGC-T is Benign according to our data. Variant chr17-57979243-TTGCTGCTGCTGCTGC-T is described in ClinVar as [Likely_benign]. Clinvar id is 2647952.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 330 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VEZF1 | NM_007146.3 | c.1032_1046delGCAGCAGCAGCAGCA | p.Gln345_Gln349del | disruptive_inframe_deletion | 5/6 | ENST00000581208.2 | NP_009077.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VEZF1 | ENST00000581208.2 | c.1032_1046delGCAGCAGCAGCAGCA | p.Gln345_Gln349del | disruptive_inframe_deletion | 5/6 | 1 | NM_007146.3 | ENSP00000462337.1 | ||
VEZF1 | ENST00000258963.7 | c.486_500delGCAGCAGCAGCAGCA | p.Gln163_Gln167del | disruptive_inframe_deletion | 4/5 | 1 | ENSP00000258963.3 | |||
VEZF1 | ENST00000584396.5 | c.1005_1019delGCAGCAGCAGCAGCA | p.Gln336_Gln340del | disruptive_inframe_deletion | 5/6 | 5 | ENSP00000464687.1 |
Frequencies
GnomAD3 genomes AF: 0.00218 AC: 329AN: 150642Hom.: 0 Cov.: 28
GnomAD3 genomes
AF:
AC:
329
AN:
150642
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00317 AC: 4588AN: 1446250Hom.: 8 AF XY: 0.00314 AC XY: 2257AN XY: 719484
GnomAD4 exome
AF:
AC:
4588
AN:
1446250
Hom.:
AF XY:
AC XY:
2257
AN XY:
719484
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00219 AC: 330AN: 150754Hom.: 0 Cov.: 28 AF XY: 0.00200 AC XY: 147AN XY: 73664
GnomAD4 genome
AF:
AC:
330
AN:
150754
Hom.:
Cov.:
28
AF XY:
AC XY:
147
AN XY:
73664
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
VEZF1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 06, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2024 | VEZF1: BP3 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at